Anita Vega-Miranda

Anita Vega-Miranda

Auto-generated profile, based on publicly available information

Anita Vega-Miranda

Laboratorio de Transducción de Señales, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2023 in Natural Product Research
Verified
Journal Article
Closed access
MEMaría Mirian Estévez-Carmona
María Mirian Estévez-Carmona
MRM. Teresa Ramírez-Apan
M. Teresa Ramírez-Apan
POPaola Montserrat Zaragoza Ojeda
Paola Montserrat Zaragoza Ojeda
AVAnita Vega-Miranda
Anita Vega-Miranda
FAFrancisco Arenas-Huertero
Francisco Arenas-Huertero
MOMarco A. Obregón-Mendoza
Marco A. Obregón-Mendoza
The new phenyl glycine derivative of perezone was obtained in a single reaction step in ca. 80% yield which showed remarkable cytotoxic activity against the astrocytoma U-251 cell line. After 24 h of exposure, both perezone (IC50 = 6.83 ± 1.64 µM) and its phenyl glycine derivative (2.60 ± 1.69 µM) showed cytotoxic effect on U-251 cells but were five times less cytotoxic on the non-tumoral SVGp12 cell line (IC50 = 28.54 ± 1.59 and 31.87 ± 1.54 µM respectively). Both compounds induced cellular morphological changes (pyknosis or cytoplasmic vacuolization) and increased the expression of caspases 3, 8, and 9 genes related to apoptosis. In the acute toxicity study, phenyl glycine perezone (DL50 = 2000 mg/Kg) demonstrated to be less toxic than perezone (DL50 = 500 mg/Kg). Phenylglycine-perezone can envisage a beneficial therapeutic potential.